Vaxon Biotech is a biopharmaceutical company focused on the treatment of cancers and related malignancies. Disease targets include breast, lung, pancreatic, and prostate cancer. The company's claim to fame is its development of optimized cryptic peptide antigens (substances that trigger protein responses in the immune system), which have shown early progress in the immune response against these cancers. The company's development products are classified as therapeutic vaccines and are developed to trigger the immune system to attack malignant cells in solid tumors while steering clear from normal cells. The Paris-based, private company was founded in 2004.
See detailed business credit reports on other businesses or your own.
See detailed profiles for insights and prospects on this company's top competitors.
Get in Touch with 5 Principals*
Jean-Pierre KINETChairman of the Board
Kostantinos KOSMATOPOULOSGeneral Manager and Board Member
Herve Jacques Ino Francois ARDITTYChief Representative
Bénédicte ICHEBoard Member